Novartis (NVS) Insider Trading & Ownership $110.31 -0.78 (-0.70%) Closing price 03/25/2025 03:58 PM EasternExtended Trading$110.83 +0.52 (+0.47%) As of 03/25/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock There is no recent insider trading on record for Novartis, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get NVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Novartis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Novartis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction4/9/2024Sheldon WhitehouseU.S. Congress Member (D-RI)Sell$95.80$1,001 - $15,0009/20/2023Sheldon WhitehouseU.S. Congress Member (D-RI)Buy$103.58$15,001 - $50,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$96.55$50,001 - $100,0004/26/2023Thomas R. CarperU.S. Congress Member (D-DE)Buy$102.54$1,001 - $15,0003/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$92.00$50,001 - $100,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$85.55$15,001 - $50,0001/31/2023Kevin HernU.S. Congress Member (R-OK)Sell$90.62$1,001 - $15,000 (Data available from 1/1/2013 forward) NVS Insider Trading Activity - Frequently Asked Questions What percentage of Novartis stock is owned by insiders? 0.01% of Novartis stock is owned by insiders. Learn more on NVS's insider holdings. Which members of congress are trading Novartis? Sheldon Whitehouse (D-RI) has sold shares of Novartis in the last year totaling $8,000. Novartis Key ExecutivesDr. Vasant Narasimhan M.D. (Age 48)Chief Executive Officer Compensation: $8.01MMr. Harry Kirsch (Age 59)Chief Financial Officer Compensation: $3.99MMr. Victor Bulto (Age 46)President of US Compensation: $3.28MDr. Patrick Horber M.D. (Age 54)President of International Compensation: $7.31MDr. Steffen Lang Ph.D. (Age 57)President of Operations Compensation: $2.34MPaul PenepentHead of Group Financial Reporting and AccountingMs. Sloan SimpsonGlobal Head of Investor RelationsDr. Klaus Moosmayer Ph.D. (Age 56)Chief Ethics, Risk & Compliance Officer Compensation: $1.55MMs. Karen L. Hale (Age 56)Chief Legal Officer Compensation: $2.34MDr. Robert Kowalski Pharm.D. (Age 56)Chief People & Organization Officer Compensation: $2.1M More Insider Trading Tools from MarketBeat Related Companies NVO Insider Trades AZN Insider Trades SNY Insider Trades GSK Insider Trades TAK Insider Trades ARGX Insider Trades ONC Insider Trades BNTX Insider Trades TEVA Insider Trades SMMT Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:NVS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
